Previous Close | 0.0231 |
Open | 0.0230 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's Range | 0.0231 - 0.0231 |
52 Week Range | 0.0100 - 0.0669 |
Volume | |
Avg. Volume | 34,378 |
Market Cap | 1.221M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | 0.41 |
EPS (TTM) | 0.0570 |
Earnings Date | Jul 15, 2020 - Jul 16, 2020 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
DORAL, FL, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), an innovative biotech company focused in nutraceutical and pharmaceutical fields, and medical devices, today announces execution of Phase I acquisition of RxCompoundstore.com, LLC. (“RxCS”) and Peaks Curative, LLC. (“PC”) as part of the Company’s new direction and announced dual phase transaction. As of November 3, 2021 RxCS and PC have become a wholly owned subsidiaries under ETST. The t
DORAL, FL, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), an innovative biotech company focused in nutraceutical and pharmaceutical fields, and medical devices, today announces its planned acquisition structure with RxCompoundstore.com, LLC. (“RxCS”), Peaks Curative, LLC. (“PC”), and JCR Medical Equipment (“JCR”), Inc. as part of the Company’s new direction announced earlier this week. The Company has discussed and plans to proceed with the acqu
DORAL, Florida, Oct. 05, 2021 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), an innovative biotech company nutraceutical and pharmaceutical fields, and medical devices, announces they have become current with the SEC, and shares updates to the market. Company regains its current status with the SEC after filing its, both, delinquent period ending March 31, 2021 year end and period ending June 30, 2021 quarter. This was achieved through the supervision of the